bioRxivMicrobiology
An efficient plasmid-based system for the recovery of recombinant vesicular stomatitis virus encoding foreign glycoproteins
M.-C. Marques, I. Andreu-Moreno, R. Sanjuan, S. F. Elena, R. Geller
Abstract
Viral glycoproteins mediate entry into host cells, thereby dictating host range and pathogenesis. In addition, they constitute the principal target of neutralizing antibody responses, making them important antigens in vaccine development. Recombinant vesicular stomatitis virus (VSV) encoding foreign glycoproteins can provide a convenient and safe surrogate system to interrogate the function, evolution, and antigenicity of viral glycoproteins from viruses that are difficult to manipulate or those requiring high biosafety levels containment. However, the production of recombinant VSV can be technically challenging. In this work, we present an efficient and robust plasmid-based system for the production of recombinant VSV encoding foreign glycoproteins. We validate the system using glycoproteins from different viral families, including arenaviruses, coronaviruses, and hantaviruses, as well as highlight their utility for studying the effects of mutations on viral fitness. Overall, the methods described herein can facilitate the study of both native and recombinant VSV encoding foreign glycoproteins and can serve as the basis for the production of VSV-based vaccines.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Leveraging Synthetic Virology for the Rapid Engineering of Vesicular Stomatitis Virus (VSV)
Chad M. Moles, Rupsa Basu, … Bruce Frederic Smith·VirusesPeer-reviewed·Oct 21, 2024
- Two point mutations in the Hantaan virus glycoproteins afford the generation of a highly infectious recombinant vesicular stomatitis virus vector
M. M. Slough, K. Chandran, R. K. Jangra·bioRxiv·Jun 26, 2018
- Mutations that positively affect Bandavirus glycoprotein function on VSV vectored vaccines
Raegan J. Petch, Philip D. Hicks, … Paul F. Bates·Journal of VirologyPeer-reviewed·Sep 24, 2026
- Optimization of the VSV G backbone for amino terminal fusion with nanobodies allowing its retargeting to receptors of therapeutic interest.
Isoline Duquénois, Stéphanie Thébault, … Yves Gaudin·Molecular Therapy OncologyPeer-reviewed·Sep 25, 2025
- The Respiratory Syncytial Virus G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-like Particle Vaccine Candidate
L. W. McGinnes-Cullen, B. Luo, … T. G. Morrison·bioRxiv·Sep 12, 2022
- Ebola virus glycoprotein domains associated with protective efficacy
B. Bhatia, W. Furuyama, … A. Marzi·bioRxiv·May 22, 2021